RapidFire® technology enables label-free screening for lead discovery and in vitro ADME applications. The technology incorporates high-throughput solid phase extraction coupled to mass spectrometric analysis with analysis times of 6-8 seconds per sample. The system enables the direct measurement of historically difficult analytes without labels or surrogates. RapidFire technology is used by 13 of the top 15 pharmaceutical companies to accelerate their drug discovery efforts.
Pharmaceutical Business Operations, Waters Corporation